Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System
Background: Immune checkpoint inhibitors (ICIs) improve cancer survival but can provoke new or worsening autoimmune disease. Objectives: To explore the association of ICIs with multiple sclerosis (MS) using the U.S. Food and Drug Administration’s Adverse Event Reporting System (FAERS) database, and...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
SAGE Publishing
2025-11-01
|
| Serie: | Therapeutic Advances in Neurological Disorders |
| Länkar: | https://doi.org/10.1177/17562864251392211 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|